Recombinant Human MMP-13 Protein, CF

Catalog # Availability Size / Price Qty
511-MM-010
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (11)
FAQs
Supplemental Products
Reviews (2)

Recombinant Human MMP-13 Protein, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-PLGL-Dpa-AR-NH2 (Catalog # ES001). The specific activity is >2,000 pmol/min/µg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived human MMP-13 protein
Leu20-Cys471
Accession #
N-terminal Sequence
Analysis
Leu20
Structure / Form
Pro form
Predicted Molecular Mass
52 kDa
SDS-PAGE
58 kDa, reducing conditions

Product Datasheets

You must select a language.

x

511-MM

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

511-MM

Formulation Supplied as a 0.2 μm filtered solution in MES, NaCl, CaCl2 and Brij-35.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials
  • Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% Brij-35 (w/v), pH 7.5 (TCNB)
  • Recombinant Human MMP-13 (rhMMP-13) (Catalog # 511-MM)
  • p-Aminophenylmercuric acetate (APMA), (Sigma, Catalog # A-9563) 100 mM stock in DMSO
  • Fluorogenic Peptide Substrate I: MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 (Catalog # ES001)
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhMMP-13 to 100 µg/mL in Assay Buffer.
  2. Add APMA to a final concentration of 1 mM.
  3. Incubate at 37 °C for 2 hours to activate.
  4. Dilute activated rhMMP-13 to 0.2 ng/µL in Assay Buffer.
  5. Dilute Substrate to 20 µM in Assay Buffer.
  6. Load 50 µL of the 0.2 ng/µL rhMMP-13 into a black well plate and start the reaction by adding 50 µL of 20 µM Substrate. Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL of 20 µM Substrate.
  7. Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively, in kinetic mode for 5 minutes.
  8. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank

     **Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).

Per Well:
  • rhMMP-13: 0.010 µg
  • Substrate: 10 µM

Background: MMP-13

Matrix metalloproteinases are a family of zinc and calcium dependent endopeptidases with the combined ability to degrade all the components of the extracellular matrix. MMP-13 (Collagenase-3) has been demonstrated to degrade a range of extracellular matrix proteins, including collagen types I, II, III, IV, IX, X and XIV, gelatin, aggrecan, perlecan and fibronectin. MMP-13 is distinguished from the other human collagenases by its effecient degradation of type II collagen. MMP-13 is expressed by fibroblasts, chrondrocytes and squamous epithelial cells. Structurally, MMP-13 may be divided into several distinct domains; a pro-domain which is cleaved upon activation; a catalytic domain containing the zinc binding site; a short hinge region and a carboxyl terminal (hemopexin-like) domain.

References
  1. Jeffery, J.J. (1998) in Collagenase 3. A.J. Barrett, et al. (eds): Handbook of Proteolytic Enzymes, San Diego: Academic Press, p. 1167.
Long Name
Matrix Metalloproteinase 13
Entrez Gene IDs
4322 (Human)
Alternate Names
CLG 3; CLG3EC 3.4.24; collagenase 3; EC 3.4.24.-; EC 3.4.24.22; EC 3.4.24.24; EC 3.4.24.35; EC 3.4.24.65; EC 3.4.24.7; MANDP1; matrix metallopeptidase 13 (collagenase 3); matrix metalloproteinase 13 (collagenase 3); Matrix metalloproteinase-13; MMP13; MMP-13

Citations for Recombinant Human MMP-13 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis
    Authors: Zhou, D;Wei, Y;Sheng, S;Wang, M;Lv, J;Zhao, B;Chen, X;Xu, K;Bai, L;Wu, Y;Song, P;Cao, L;Zhou, F;Zhang, H;Shi, Z;Su, J;
    Bioactive materials
    Species: N/A
    Sample Types: RNA
    Applications: Bioassay
  2. dsRNA Induced IFNbeta-MMP13 Axis Drives Corneal Wound Healing
    Authors: X Lan, W Zhang, J Zhu, H Huang, K Mo, H Guo, L Zhu, J Liu, M Li, L Wang, C Liu, J Ji, H Ouyang
    Investigative Ophthalmology & Visual Science, 2022-02-01;63(2):14.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Tissue Culture
  3. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
    Authors: S Mancarella, G Serino, F Dituri, A Cigliano, S Ribback, J Wang, X Chen, DF Calvisi, G Giannelli
    Cell Death Differ., 2020-02-10;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  4. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11
    Authors: AM Knapinska, M Hart, G Drotleff, GB Fields
    Molecules, 2019-11-28;24(23):.
    Species: Human
    Sample Types: Peptide
    Applications: Bioassay
  5. Development of an inflammatory tissue-selective chimeric TNF receptor
    Authors: CJ Lee, CC Wang, M Chen, KH Chuang, TL Cheng, TY Jian, YM Wang, TH Huang, KW Liao, SC Tzou
    Cytokine, 2018-10-21;0(0):.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: Bioassay
  6. Novel Arginine-containing Macrocyclic MMP Inhibitors: Synthesis, 99mTc-labeling, and Evaluation
    Authors: Y Ye, J Toczek, K Gona, HY Kim, J Han, M Razavian, R Golestani, J Zhang, TL Wu, M Ghosh, JJ Jung, MM Sadeghi
    Sci Rep, 2018-08-03;8(1):11647.
    Species: Human
    Sample Types: Peptide
    Applications: Enzyme Assay
  7. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
    Authors: He Y, Zheng Q, Jiang M, Sun S, Christiansen T, Kassem M, Karsdal M, Bay-Jensen A
    PLoS ONE, 2015-04-24;10(0):.
    Applications: Western Blot
  8. IL-1beta-induced matrix metalloproteinase-13 is activated by a disintegrin and metalloprotease-28-regulated proliferation of human osteoblast-like cells.
    Authors: Ozeki N, Kawai R, Yamaguchi H, Hiyama T, Kinoshita K, Hase N, Nakata K, Kondo A, Mogi M, Nakamura H
    Exp Cell Res, 2014-03-05;323(1):165-77.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  9. Resistance of corneal RFUVA-cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.
    Authors: Zhang Y, Mao X, Schwend T, Littlechild S, Conrad G
    Invest Ophthalmol Vis Sci, 2013-02-05;54(2):1014-25.
    Species: Bovine
    Sample Types: Protein
    Applications: Enzyme Assay
  10. Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.
    Authors: Devel L, Beau F, Amoura M, Vera L, Cassar-Lajeunesse E, Garcia S, Czarny B, Stura E, Dive V
    J Biol Chem, 2012-06-11;287(32):26647-56.
    Applications: Enzyme Assay
  11. Chondrocyte hypertrophy and apoptosis induced by GROalpha require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B.
    Authors: Olivotto E, Vitellozzi R, Fernandez P, Falcieri E, Battistelli M, Burattini S, Flamigni F, Santi S, Borzi RM
    J. Cell. Physiol., 2007-02-01;210(2):417-27.
    Applications: ELISA (Standard)

FAQs

  1. Can the enzyme be stored after activation, or do I need to use it immediately after activation?

    • We recommend only activating the amount of enzyme needed for your assay, and recommend activating the enzyme immediately prior to use. Any unactivated enzyme should be stored in aliquots at either the stock concentration at which the enzyme was supplied, or the reconstitution concentration, according to the product datasheet.

  2. If I use this enzyme at a higher concentration, do I need to change the concentration of APMA to activate it?

    • We have only optimized activation conditions for one particular concentration of this MMP enzyme as part of our regular QC testing for enzymatic activity. Activating the enzyme at any different concentration would have to be optimized by the end user.

  3. Does this MMP enzyme need to be activated to work?

    • Yes, this enzyme requires activation prior to use.

  4. What is the activity of this enzyme in units/µg?

    • We supply this enzyme as a mass and calculate its activity relative to mass (pmol/min/µg). We have not calibrated this enzyme to an international standard unit, so we are unable to provide a conversion to units/µg.

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human MMP-13 Protein, CF

Average Rating: 5 (Based on 2 Reviews)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human MMP-13 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human MMP-13 Protein, CF
By Andres Ocampo Carrillo on 03/04/2023
Application: In vitro bioactivity in cell culture
Reason for Rating: The protein was very practical to dissolve, aliquot, and use without losing enzymatic activity.

Recombinant Human MMP-13 Protein, CF
By Anonymous on 11/10/2017
Application: Immunoassay Standard